Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Amgen Announces Robust Weight Loss With MariTide in People Living With Obesity or Overweight at 52 Weeks in a Phase 2 Study

Amgen (NASDAQ AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide (maridebart cafraglutide, formerly AMG

Study Finds GLP-1 Meds, such as Ozempic, Wegovy, Can Also Help the Kidneys

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up New research shows they may also shield your kidneys from harm. In the large

Program Tripled Number of Completed At-Home Colon Cancer Tests

People are three times more likely to undergo at-home colon cancer screening if they re provided a free test, a new study says. About 30 of patients mailed a fr

Scientists Spot Gene That Could Help Cause Miscarriages

A gene that causes accelerated reproductive aging is directly tied to the risk of miscarriage in younger women, a new study says. A mutation of the gene KIF18A

Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds, such as Wegovy, Zepbound

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medi

Panel of Biomarkers Can Distinguish Stable, Exacerbation States in COPD

A panel of biomarkers can distinguish between stable and exacerbation states in chronic obstructive pulmonary disease (COPD), and an artificial neural network (

Exposures to Eight Factors Contribute to Increasing Trends in IHD, Stroke

Altered exposures to eight factors contribute to increasing trends in ischemic heart disease (IHD) and stroke on a global scale, according to a study published

Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective

Vaccination of 27- to 45-year-olds ( mid-adults ) against human papillomavirus (HPV) is less cost-effective than vaccination of younger persons (aged 9 to 26 ye

AHA: Variation Seen in Rates of SGLT2i Rx for Heart Failure, LVEF >40 Percent

From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for patients with heart failure and a left

COVID-19, Flu, RSV Vaccine Coverage Low for Nursing Home Residents

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents early in the 2024 to 2025 season, according

Popular Keywords